Hagop H. Kozanian - Feb 9, 2022 Form 4 Insider Report for TEXAS INSTRUMENTS INC (TXN)

Role
Sr. Vice President
Signature
/s/ Katharine Kane, Attorney In Fact
Stock symbol
TXN
Transactions as of
Feb 9, 2022
Transactions value $
-$2,382,194
Form type
4
Date filed
2/11/2022, 03:51 PM
Previous filing
Jan 31, 2022
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXN Common Stock Options Exercise $593K +5.38K +9.28% $110.15 63.4K Feb 9, 2022 Direct
transaction TXN Common Stock Options Exercise $1.18M +11.3K +17.86% $104.41 74.8K Feb 9, 2022 Direct
transaction TXN Common Stock Options Exercise $1.91M +14.7K +19.62% $130.52 89.4K Feb 9, 2022 Direct
transaction TXN Common Stock Sale -$4.11M -23.6K -26.41% $174.13 65.8K Feb 9, 2022 Direct F1
transaction TXN Common Stock Sale -$1.96M -11.2K -17% $175.15 54.6K Feb 9, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -5.38K -100% $0.00* 0 Feb 9, 2022 Common Stock 5.38K $110.15 Direct F3
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -11.3K -50% $0.00 11.3K Feb 9, 2022 Common Stock 11.3K $104.41 Direct F4
transaction TXN NQ Stock Option (Right to Buy) Options Exercise $0 -14.7K -33.33% $0.00 29.3K Feb 9, 2022 Common Stock 14.7K $130.52 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $173.73 to $174.72. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $174.745 to $175.69. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.
F4 The option became exercisable in four equal annual installments beginning on January 25, 2020.
F5 The option became exercisable in four equal annual installments beginning on January 24, 2021.